about
Impact of efficacy at the μ-opioid receptor on antinociceptive effects of combinations of μ-opioid receptor agonists and cannabinoid receptor agonists.Effects of amphetamine on delay discounting in rats depend upon the manner in which delay is variedAdditive antinociceptive effects of mixtures of the κ-opioid receptor agonist spiradoline and the cannabinoid receptor agonist CP55940 in ratsImpulsivity and drugs of abuse: a juice-reinforced operant procedure for determining within-session delay discounting functions in rhesus monkeysDelay discounting of the μ-opioid receptor agonist remifentanil in rhesus monkeys.Effect of daily morphine administration and its discontinuation on delay discounting of food in rhesus monkeysEffects of daily delta-9-tetrahydrocannabinol treatment on heroin self-administration in rhesus monkeys.Interactions between μ-opioid receptor agonists and cannabinoid receptor agonists in rhesus monkeys: antinociception, drug discrimination, and drug self-administration.Daily morphine administration increases impulsivity in rats responding under a 5-choice serial reaction time taskDeterminants of choice, and vulnerability and recovery in addiction.Effect of delay on self-administration of remifentanil under a drug versus drug choice procedure in rhesus monkeysEffects of amphetamine and methylphenidate on delay discounting in rats: interactions with order of delay presentation.Interactions between cannabinoid receptor agonists and mu opioid receptor agonists in rhesus monkeys discriminating fentanyl.Antinociceptive effects of mixtures of mu opioid receptor agonists and cannabinoid receptor agonists in rats: Impact of drug and fixed-dose ratio.Rapid acquisition of preference in concurrent schedules: effects of reinforcement amount.Effects of daily morphine treatment on impulsivity in rats responding under an adjusting stop-signal reaction time taskDrug Discrimination and the Analysis of Private EventsImpact of order of fixed-ratio presentation on demand for self-administered remifentanil in male ratsOREX-1019: A Novel Treatment of Opioid Use Disorder and Relapse PreventionEffects of the synthetic cannabinoid receptor agonist JWH-018 on abuse-related effects of opioids in rhesus monkeysEffects of amphetamine, methylphenidate, atomoxetine, and morphine in rats responding under an adjusting stop signal reaction time taskBehavioral Pharmacology of Drugs Acting at Mu Opioid ReceptorsEffects of acute and repeated treatment with methocinnamox, a mu opioid receptor antagonist, on fentanyl self-administration in rhesus monkeys
P50
Q34360705-D62EC54C-5B42-4573-ACB4-7302FF8CE0B0Q34403937-53BC0E67-AD76-4110-A0FC-D09BE50EB625Q36387010-1D751314-BE80-4DB0-92CC-BE194E279E15Q36427966-5CE8B6F8-873B-4C4B-8D42-E52873CD6A05Q36655679-D3E31DDF-2E66-4CCC-913F-3E09309F626BQ36655864-9E9F6507-38C3-44B2-8A2F-9489F185A967Q36655914-43A09B8F-CCDF-4A0A-887B-87DD7E7048A3Q36852576-89D4FD49-18F1-4586-97C0-EDDFCE9DEF5DQ37084871-CFAB8358-719B-4B25-BE7C-CCEAC97FBB6EQ37142653-E1A6C3FD-8ADD-4F00-8E4D-3E8DAAF7FED8Q37331840-0E4E72CB-76B7-4223-8F84-5FB70A115118Q37424552-17E28528-8A3B-4581-98F5-4E9D0351F0E8Q39762143-75A29DA0-FCF8-429B-B1DD-3EC9AF98BC88Q47777896-10685E11-03C9-4AC5-9C5E-89A5F1F83BD4Q51989608-2C5730EE-60AE-4BA5-A06F-FE895E0C9621Q88212209-5C9C00C4-683F-4627-B351-FBA28EB96E44Q88923230-1523E044-9969-4A44-999C-C25E9B9738D3Q90436637-5C037810-9137-47EE-B1D3-146FEDF6A997Q91361357-0010E182-E493-4148-8FBE-82648796B7F5Q91800178-5D85007B-81AF-47FE-BA15-3F0FA51285C1Q91860703-E577F964-2346-4376-B311-4685CB1DD519Q92884746-5B76C7AC-4260-457B-B288-4EA95743BE0BQ94581130-444183BF-53AD-4DFA-861B-90AF92D3F2C3
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
David R Maguire
@nl
David R Maguire
@sl
David R. Maguire
@en
David R. Maguire
@es
type
label
David R Maguire
@nl
David R Maguire
@sl
David R. Maguire
@en
David R. Maguire
@es
prefLabel
David R Maguire
@nl
David R Maguire
@sl
David R. Maguire
@en
David R. Maguire
@es
P106
P1153
16230873800
P21
P31
P496
0000-0002-0958-5397